Showing 1 - 9 results of 9 for search 'Johannes H. A. M. Kaanders', query time: 0.04s
Refine Results
-
1
Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma by Maurice C. Cox, Tijn Jurcka, Anne I. J. Arens, Maartje C. van Rijk, Johannes H. A. M. Kaanders, Sven van den Bosch
Published 2023-10-01
Article -
2
Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer by Maria T. Brands, Elisabeth A. J. Smeekens, Robert P. Takes, Johannes H. A. M. Kaanders, Andre L. M. Verbeek, Matthias A. W. Merkx, Sandra M. E. Geurts
Published 2019-09-01
Article -
3
-
4
-
5
Assessing radiation-induced carotid vasculopathy using ultrasound after unilateral irradiation: a cross-sectional study by Judith T. Pruijssen, Joyce Wilbers, Frederick J. A. Meijer, Sjoert A. H. Pegge, Jacqueline J. Loonen, Chris L. de Korte, Johannes H. A. M. Kaanders, Hendrik H. G. Hansen
Published 2022-07-01
Article -
6
Validation of automated positive cell and region detection of immunohistochemically stained laryngeal tumor tissue using digital image analysis by Hilde J.G. Smits, Justin E. Swartz, Marielle E.P. Philippens, Remco de Bree, Johannes H.A.M. Kaanders, Sjors A. Koppes, Gerben E. Breimer, Stefan M. Willems
Published 2023-01-01
Article -
7
Individualised follow-up for head and neck cancer—design of a prospective cohort study to assess its feasibility by Cecile van de Weerd, Julia J. van Tol-Geerdink, Guido B. van den Broek, Johannes H.A.M. Kaanders, Henri A.M. Marres, Rosella P.M.G. Hermens, Robert P. Takes
Published 2022-12-01
Article -
8
Novel Diagnostic Approaches for Assessment of the Clinically Negative Neck in Head and Neck Cancer Patients by Daphne A. J. J. Driessen, Tim Dijkema, Willem L. J. Weijs, Robert P. Takes, Sjoert A. H. Pegge, Patrik Zámecnik, Adriana C. H. van Engen-van Grunsven, Tom W. J. Scheenen, Johannes H. A. M. Kaanders
Published 2021-02-01
Article -
9
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset by Lieke in 't Ven, Erik Roelofs, Macarena Cubillos Mesías, Inge Compter, Yvonne L.B. Klaver, Robert Jan Smeenk, Geert O. Janssens, Johannes H.A.M. Kaanders, Raquel Davila Fajardo, Foppe Oldenburger, Dirk de Ruysscher, Esther G.C. Troost, Daniëlle B.P. Eekers
Published 2021-05-01
Article